ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Cancer
Ovarian Cancer
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck

Breast Cancer trials near Berlin, BE, DEU:

A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer (VERITAC-2)

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Berlin, Germany and 319 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 144 other locations

with HR-positive, HER2-negative locally advanced or metastatic breast cancer with gBRCA1/2 mutation, with 2:1 randomization into Ar...

Enrolling
Advanced or Metastatic Breast Cancer
Hormone Receptor Positive HER-2 Negative Breast Cancer
Drug: Olaparib + Elacestrant
Drug: Olaparib

Phase 2

GBG Forschungs GmbH

Berlin, State of Berlin, Germany and 35 other locations

Locations recently updated

The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...

Active, not recruiting
Metastatic Breast Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

DualityBio

Berlin, State of Berlin, Germany and 257 other locations

(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab Deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 80 other locations

This is a single-arm, open-label phase IV study of patients with advanced HR+/HER2- breast cancer who are treated first line with r...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Ribociclib

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 51 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Trastuzumab deruxtecan
Drug: Capecitabine

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 292 other locations

elacestrant vs standard endocrine therapy in patients with ER+/HER2- breast cancer and ctDNA relapse.During the ctDNA screening pha...

Enrolling
ER-positive Breast Cancer
Stage IIB Breast Cancer
Drug: Exemestane 25 MG
Drug: Anastrozole 1mg

Phase 3

European Organisation for Research and Treatment of Cancer (EORTC)

Potsdam, Germany and 111 other locations

treatment of HR-positive, HER2-negative advanced or metastatic breast cancer.HR-positive breast cancer cells have...

Enrolling
Breast Cancer
Drug: Fulvestrant
Drug: Exemestane

Phase 3

Pfizer
Pfizer

Berlin, Germany and 205 other locations

Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy a...

Active, not recruiting
HER2-Positive Primary Breast Cancer
Residual Invasive Breast Cancer
Drug: DS-8201a
Drug: T-DM1

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Berlin, Germany and 483 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems